Johnson & Johnson just announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate where it will look to enroll up to 60,000 volunteers across three continents.
Latest market news
Today 12:04 PM
Today 12:54 AM